Skip to main content
Clinical Trials/DRKS00033127
DRKS00033127
Completed
未知

Pharmacist-assisted implementation of guideline recommendations for QTc monitoring during psychopharmacotherapy - a prospective, randomised feasibility study - PHARMQT

Zentrum für Integrative Psychiatrie0 sites160 target enrollmentNovember 28, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
R94.3
Sponsor
Zentrum für Integrative Psychiatrie
Enrollment
160
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 28, 2023
End Date
July 12, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Zentrum für Integrative Psychiatrie

Eligibility Criteria

Inclusion Criteria

  • Admission to wards B3\.01, B3\.11, B6\.01 and to the day clinic B22
  • \- Expected length of stay at least 30 days
  • \- Use of at least one QT\-prolonging drug during the stay (known, possible or conditional risk according to CredibleMeds)
  • \- Signed declaration of consent

Exclusion Criteria

  • \- Patients who are not taking a QT\-prolonging drug during the study period
  • \- Patients who sleep on the psychiatric wards but who are hospitalized for somatic treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials